Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Okta, Inc. (OKTA) vs Koninklijke Philips NV (PHG) Price & Performance

Okta, Inc.Trade
Koninklijke Philips NVTrade

Price performance (Past 24H)

Key statistics

Okta, Inc. vs Koninklijke Philips NV — how do they compare? Okta, Inc. trades at $225.9 (market cap $38.50B), while Koninklijke Philips NV trades at $24.32 (market cap $23.52B). The key difference: Okta, Inc. is the larger of the two by market cap, and Koninklijke Philips NV pays a 4.17% dividend while Okta, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Okta, Inc. for 44 Days and Koninklijke Philips NV for 84 Days on average.

OKTAPHG
Market Cap
$38.50B$23.52B
Volume
2,479,6211,635,069
Sector
TechnologyHealth
52-Week High
$220.21$32.91
52-Week Low
$62.93$23.81
Typical Hold Time
44 Days84 Days
Enterprise Value
$36.25B$29.87B
Dividend Yield
—4.17%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Okta, Inc.

OKTA trades at $218.00, down slightly by 0.31% on the day, with a bullish technical signal from moving averages and strong quarterly earnings beats. The company reported a net income of $28 million in 2025, marking a significant turnaround from previous losses, while revenue grew to $2.61 billion. Recent news highlights its AI agent security initiatives, including the Blueprint Alliance unveiled at Oktane 2026.

Outlook remains positive with robust analyst support (73.58% buy ratings) and a consensus price target of $201.30, though high valuation ratios and overbought RSI readings pose near-term risks. Long-term growth is supported by identity management demand and AI positioning, but competition and execution challenges are key investor considerations.

Koninklijke Philips NV

PHG trades at $24.09, down 0.25% with a bearish technical signal. The company shows improving fundamentals with three consecutive quarterly EPS beats and a return to profitability in 2025 (net income $895M). Recent news highlights innovation in healthcare technology including new product launches and AI partnerships. Valuation metrics appear reasonable with P/E of 18.94 and P/S of 1.18.

PHG presents a mixed outlook with strong operational recovery but technical weakness. The investment case hinges on continued earnings momentum and successful execution of healthcare technology initiatives. Key risks include competitive pressures and potential cybersecurity vulnerabilities following recent hacking incidents. Analyst consensus leans neutral with 36% buy ratings versus 64% hold.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

OKTA
70% Buy30% Sell
Avg holding period · 44 Days
PHG

No sentiment data available yet.

About Okta, Inc.

Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.

Read more on OKTA →

About Koninklijke Philips NV

Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.

Read more on PHG →